Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Parasitol ; 130(1-2): 105-13, 2005 Jun 10.
Article in English | MEDLINE | ID: mdl-15893077

ABSTRACT

The objective of this study was to evaluate effects of the condensed tannin (CT)-containing forage sericea lespedeza (sericea lespedeza (SL); Lespedeza cuneata; 15.2% CT), on fecal egg count (FEC), larval development (larvae/10 g of feces), worm burden and immune response compared with a crabgrass (Digitaria ischaemum)/Kentucky 31 tall fescue (Festuca arundinacea; control forage (CTF)) forage low in CT (0.32% CT) in grazing Angora does and their kids. Fifty worm-free mixed-age does were randomly allocated to three treatments. One treatment (10 does; initial liveweight (LW) = 45+/-1.5 kg) entailed grazing of SL forage from April 25 to July 15, 2002 with a second treatment of CTF (20 does; initial LW = 43+/-1.4 kg) grazing during the same period. Does of the third treatment (20 does; initial LW = 44+/-1.4 kg) grazed a sward of SL for 2 weeks and then one of CTF for 2 weeks followed by alternating between the two pastures every 2-week rotational grazing (ROT). To gauge levels of infective larvae on pasture, three worm-free Angora kids (initial LW = 3.6+/-0.2 kg) were randomly selected as tracers. Tracers grazed for final 60 days and were euthanized for determination of worm burden. The immune response of does was measured by skin thickness reaction after the intradermal injection of 250 microg phytohemagglutinin (PHA). Mean FEC for SL and ROT were substantially lower (P < 0.01) than for CTF does (145, 329 and 894 eggs/g, respectively). The FEC for kids was lower (P < 0.05) for SL than for ROT and CTF (550, 2757 and 3600 eggs/g, respectively). Total fecal egg output (3.3, 6.0 and 26.9 x 10(5) eggs/day, respectively) and larval development (242, 263 and 792 larvae/10 g, respectively) were lower (P < 0.05) for SL and ROT than for CTF. Tracers grazing on SL had lower total worm burdens than ROT and CTF (P < 0.01). The immune response was higher (P < 0.01) for SL (4.9 mm) and ROT (6.0 mm) than for CTF (3.0 mm) at 12 h after injection of PHA. The packed cell volume (PCV) in does was higher (P < 0.01) for SL and ROT than for CTF (27, 26 and 23%, respectively). Does that grazed CT-containing forage had considerably lower milk somatic cell counts (SCC) than does grazing non-CT-containing forage. In summary, grazing CT forages reduced FEC, larval development and worm burden, and also appeared to enhance immune response. The CT-containing forage SL reduced gastro-intestinal parasite infections of Angora does and kids.


Subject(s)
Animal Feed , Gastrointestinal Diseases/drug therapy , Gastrointestinal Diseases/veterinary , Goat Diseases/parasitology , Proanthocyanidins/administration & dosage , Trichostrongyloidea/growth & development , Trichostrongyloidiasis/drug therapy , Trichostrongyloidiasis/veterinary , Animals , Animals, Suckling , Digitaria , Feces/parasitology , Female , Festuca , Gastrointestinal Diseases/immunology , Gastrointestinal Diseases/parasitology , Goat Diseases/immunology , Goats , Hematocrit/veterinary , Hypersensitivity , Lespedeza , Milk/chemistry , Milk/cytology , Parasite Egg Count/veterinary , Trichostrongyloidiasis/immunology , Trichostrongyloidiasis/parasitology , Urea/blood
2.
J Dairy Sci ; 84(4): 814-7, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11352157

ABSTRACT

Dairy heifers were treated 0 to 90 d, 90 to 180 d, or 180 to 270 d prepartum with one of five different antibiotic products to determine the best time and with which product they should be treated prior to calving. Two hundred thirty-three heifers were included in the study. At the initial sampling, 56.5% of quarters were infected with some type of organism and 15.4% of quarters were infected with Staphylococcus aureus. Treatments included a cephapirin dry cow product, a penicillin-novobiocin dry cow product, a penicillin-streptomycin dry cow product, an experimental dry cow product containing tilmicosin, and a cephalonium dry cow product not available in the United States. Cure rates for the five antibiotic products indicated that all were equally effective against Staph. aureus and all were significantly more effective than the spontaneous cure rate observed in untreated control quarters. No differences in efficacy were observed due to the different treatment times prepartum. However, fewer new Staph. aureus infections occurred after treatment in the group treated at 180 to 270 d prepartum, indicating that treatment in the third trimester will reduce the chances of new intramammary infections occurring after treatment and persisting to calving.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cephapirin/therapeutic use , Mastitis, Bovine/drug therapy , Mastitis, Bovine/epidemiology , Staphylococcal Infections/veterinary , Staphylococcus aureus/drug effects , Animals , Anti-Bacterial Agents/administration & dosage , Cattle/physiology , Cephapirin/administration & dosage , Drug Combinations , Female , Novobiocin/administration & dosage , Novobiocin/therapeutic use , Penicillins/administration & dosage , Penicillins/therapeutic use , Pregnancy , Prevalence , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology , Staphylococcus aureus/pathogenicity , Time Factors , Treatment Outcome
3.
J Dairy Sci ; 83(10): 2276-81, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11049068

ABSTRACT

The efficacy of two commercially available Escherichia coli J5 bacterins was investigated. Jersey cows were randomly assigned to one of three treatment groups: 1) unvaccinated controls, 2) vaccinated with J.VAC (Merial Limited, Athens, GA), and 3) vaccinated with J5 bacterin. All cows were vaccinated at drying off and at 2 wk before anticipated calving. Cows that were vaccinated with the J5 bacterin also received a third immunization at calving. One quarter of each cow was challenged with approximately 64 cfu of E. coli at 14 to 30 d postcalving. Immunization by either vaccine did not influence the severity of coliform mastitis; however, the mean number of colony-forming units of E. coli recovered from challenged quarters was significantly lower for immunized cows than for control cows at 144 h postchallenge. Serum and mammary secretion immunoglobulin (Ig)G, IgG1, and IgG2 titers against E. coli J5 whole-cell antigens were enhanced in vaccinated cows. Serum and mammary secretion IgM were not different among treatment groups. Somatic cell counts in milk from challenged quarters, rectal temperatures, and the clinical status of cows following intramammary challenge were not different among treatment groups.


Subject(s)
Bacterial Vaccines/administration & dosage , Escherichia coli Infections/veterinary , Escherichia coli/immunology , Mastitis, Bovine/prevention & control , Animals , Antibodies, Bacterial/blood , Cattle , Cell Count/veterinary , Colony Count, Microbial , Escherichia coli Infections/prevention & control , Female , Immunoglobulin G/blood , Immunoglobulin M/blood , Lactation , Mastitis, Bovine/microbiology , Milk/cytology
4.
J Dairy Sci ; 83(10): 2269-75, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11049067

ABSTRACT

We conducted the following study to determine if bispecific antibodies enhance the bactericidal activity of bovine neutrophils. Bispecific antibodies were synthesized by chemically crosslinking bovine neutrophil monoclonal antibodies to Staphylococcus aureus 305 capsule polysaccharide monoclonal antibodies. The efficiency of chemically coupling monoclonal antibody monomers was approximately 50% for each bispecific antibody produced. Monoclonal antibodies against neutrophils enhanced the respiratory burst activity of neutrophils by 2.3- to 2.5-fold. To determine the influence of bispecific antibodies on neutrophil function, S. aureus 305 was preincubated with various concentrations of bispecific antibodies and neutrophils were then added to the opsonized bacteria at different bacteria to neutrophil ratios. The bactericidal activity of neutrophils was expressed as a percentage reduction in colony-forming units in test cultures compared with the number of colony-forming units in control test cultures that did not contain bispecific antibodies or neutrophils. The addition of bispecific antibodies to test cultures increased the bactericidal activity of neutrophils. A reduction in colony-forming units as a function of increasing the S. aureus 305 to neutrophils ratio was observed in both the absence and presence of bispecific antibodies. However, a greater reduction was observed in the presence of bispecific antibodies. Increasing concentrations of bispecific antibodies enhanced the bactericidal activity of neutrophils at a constant S. aureus 305 to neutrophil ratio of 1:500. The results indicate that bispecific antibodies that recognize both S. aureus 305 capsular polysaccharide and neutrophil antigens potentiate the bactericidal activity of neutrophils.


Subject(s)
Antibodies, Bispecific/immunology , Mastitis, Bovine/immunology , Neutrophils/physiology , Staphylococcus aureus/immunology , Animals , Antibodies, Bispecific/therapeutic use , Antibodies, Monoclonal/immunology , Bacterial Capsules/immunology , Blood Bactericidal Activity , Cattle , Colony Count, Microbial , Female , Immunotherapy/veterinary , Mastitis, Bovine/therapy , Neutrophils/drug effects , Neutrophils/immunology , Respiratory Burst/immunology , Time Factors
5.
J Dairy Sci ; 81(8): 2159-64, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9749381

ABSTRACT

The route of immunization of a commercially available Escherichia coli J5 bacterin was investigated. Jersey cows were randomly assigned to one of three treatment groups: 1) unvaccinated (control), 2) vaccinated subcutaneously in the neck, and 3) vaccinated in the area of the supramammary lymph node. Cows were vaccinated at drying off and at 2 wk prior to anticipated calving. Two quarters of each cow were challenged with approximately 60 cfu of E. coli at 14 d postcalving. Route of immunization in the neck or the area of the supramammary lymph node did not influence severity of coliform mastitis. However, the mean number of colony-forming units of E. coli recovered from challenged quarters was significantly lower for vaccinated cows than for control cows at 24 h postchallenge. A quicker milk yield recovery following intramammary challenge was also observed for vaccinated cows. Serum immunoglobulin (Ig) G, IgG1, and IgG2 and whey IgG1 and IgG2 antibody titers against E. coli J5 whole-cell antigens were significantly enhanced in vaccinated cows. Somatic cell counts in milk from challenged quarters and rectal temperatures following intramammary challenge were not different for cows across treatment groups. Immunization did not prevent intramammary infection.


Subject(s)
Bacterial Vaccines/administration & dosage , Escherichia coli Infections/veterinary , Mastitis, Bovine/prevention & control , Animals , Antibodies, Bacterial/blood , Cattle , Cell Count , Escherichia coli/growth & development , Escherichia coli/immunology , Escherichia coli/isolation & purification , Escherichia coli Infections/prevention & control , Female , Immunoglobulin G/blood , Kinetics , Lactation , Lymph Nodes , Mammary Glands, Animal , Mastitis, Bovine/microbiology , Milk/cytology , Neck
6.
J Dairy Sci ; 78(12): 2745-52, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8675757

ABSTRACT

We investigated a possible mechanism by which immunization against core and lipid A determinants of lipopolysaccharide reduced clinical cases of mastitis and symptoms commonly associated with heterologous Gram-negative IMI. The IgG fraction of sera from cows immunized with either Escherichia coli J5 bacterin, E. coli J5 lipopolysaccharide conjugate vaccine, or unimmunized controls was purified by precipitation with caprylic acid and ammonium sulfate. The degree of IgG crossreactivity with Gram-negative bacteria that were isolated from clinical quarters was greater than that with Gram-positive isolates of Staphylococcus aureus. The highest magnitude of crossreactivity was against smooth strain E. coli isolates, followed by heterologous species of Enterobacter, Serratia, and Klebsiella isolates. Serum IgG from cows immunized with conjugate was highly crossreactive to E. coli J5, E. coli O111:B4, Serratia marcescens, Klebsiella pneumoniae, and Salmonella typhimurium lipopolysaccharides. The magnitude of antibody crossreactivity with lipopolysaccharides coincided with the ability of IgG to suppress the mitogenic effect of lipopolysaccharides on bovine lymphocytes.


Subject(s)
Antigens, Bacterial/immunology , Cattle/immunology , Immunoglobulin G/immunology , Lipopolysaccharides/immunology , Ammonium Sulfate , Animals , Antibody Specificity , Bacterial Vaccines/immunology , Caprylates , Chemical Precipitation , Enterobacter/immunology , Escherichia coli/immunology , Female , Immunization , Klebsiella/immunology , Lipid A/immunology , Mastitis, Bovine/prevention & control , Serratia/immunology
7.
J Dairy Sci ; 78(10): 2178-85, 1995 Oct.
Article in English | MEDLINE | ID: mdl-8598402

ABSTRACT

Development of a lipopolysaccharide-protein conjugate vaccine and the immunological response to the vaccine were investigated. Lipopolysaccharide derived from Escherichia coli J5 was detoxified by mild alkaline hydrolysis. Detoxification reduced endotoxin activity 2500-fold compared with that of native J5 lipopolysaccharide. The conjugate vaccine was synthesized by covalently coupling detoxified lipopolysaccharide to chicken serum albumin by reductive amination. Dairy cows were immunized with 8.35 mg of conjugate (n = 3) or 5 x 10(9) heat-killed J5 bacterin (n = 5) at 215 DIM and received a secondary immunization 14 d later. Control cows were not immunized. Immunization enhanced serum antibody titer to J5 lipopolysaccharide antigens. Whey IgG and IgM titers to J5 lipopolysaccharide were not different among treatment groups. Serum and whey IgG titers to J5 whole-cell antigens were elevated in immunized cows within treatment groups. Immunization did not enhance whey IgM to J5 whole-cell antigens. Conjugate immunization elicited an immune response comparable with or greater than that of immunized cows with J5 bacterin.


Subject(s)
Bacterial Vaccines , Escherichia coli Infections/prevention & control , Immunization , Lipopolysaccharides/immunology , Mastitis, Bovine/prevention & control , Animals , Antibodies, Bacterial/blood , Cattle , Cell Count , Chickens , Female , Immunoglobulin G/blood , Immunoglobulin M/blood , Mastitis, Bovine/microbiology , Milk/cytology , Serum Albumin/immunology
8.
J Dairy Sci ; 75(1): 72-7, 1992 Jan.
Article in English | MEDLINE | ID: mdl-1541744

ABSTRACT

Six pairs of cows were used to determine the effects of immunization with an Escherichia coli (O111:B4) J5 bacterin on in vitro opsonization of a smooth heterologous strain of E. coli. One cow in each pair was either immunized with the vaccine or sham-immunized at drying off, 30 d after drying off, and at calving. Opsonizing bacteria with serum collected from vaccinated cows 21 d after calving resulted in higher mean number of intracellular bacteria per phagocytosing neutrophil than opsonizing bacteria with serum collected from control cows. Phagocytic parameters using serum collected at drying off and calving did not differ between treatment groups. A trend for enhanced opsonic activity of colostrum from vaccinates was noted. Enhanced opsonization by serum from vaccinated cows coincided with higher serum IgM titer to E. coli J5 whole cell antigen compared with controls. Serum IgG titers to E. coli J5 did not differ between groups. Colostrum IgG titers to E. coli J5 were greater at calving in vaccinated than in control cows. Colostrum and milk collected 21 d after calving from vaccinated cows had higher IgM titers to E. coli J5 than did mammary secretions from control cows. Numbers of intracellular bacteria per phagocytizing neutrophil were correlated positively with IgM titers to E. coli J5 in both serum and colostrum.


Subject(s)
Antibodies, Bacterial/analysis , Bacterial Vaccines/immunology , Escherichia coli/immunology , Mammary Glands, Animal/immunology , Opsonin Proteins/immunology , Animals , Antibodies, Bacterial/blood , Cattle , Colostrum/immunology , Escherichia coli Infections/prevention & control , Escherichia coli Infections/veterinary , Escherichia coli Vaccines , Female , Immunoglobulin G/analysis , Immunoglobulin G/blood , Immunoglobulin M/analysis , Immunoglobulin M/blood , Mastitis, Bovine/prevention & control , Neutrophils/immunology , Opsonin Proteins/blood , Phagocytosis , Vaccination/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...